The field of bispecific antibodies is advancing rapidly with results demonstrating their effective use in immunotherapy and oncology, as well as applications that are emerging in ophthalmology, infectious disease, and inflammation. This conference will highlight novel engineering approaches to bispecific antibody constructs and reveal key elements for efficacy and drug-like properties. The latest improvements in manufacturing, purification, stability, enhanced targeting, modulating immune response, expression, characterization, humanization and clearance will be shared.

Key strategies and technologies to:

  • Design bispecific antibodies against infectious disease and inflammation targets
  • Assess technologies to cross the blood brain barrier
  • Minimize immunogenicity and toxicity
  • Optimize production techniques
  • Improve expression, purification, clearance, solubility and stability
  • Employ approaches for immunomodulation and immunotherapy

Scientists who wish to present their knowledge and expertise to their colleagues are asked to click here to submit an abstract.  Remember to specify the conference that you are interested in and please provide your full contact information.

The deadline for submission is Friday, September 25, 2015.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program.  Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:

For partnering and sponsorship information, please contact:

Christina Lingham
Executive Director, Conferences
Phone: 781-972-5464

Jason Gerardi
(Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: 781-972-5452

Carol Dinerstein
(Companies L-Z)
Director, Business Development
Cambridge Healthtech Institute
T: 781.972.5471